Crinecerfont shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Crinecerfont
- Brand names
- Crenessity
- Class
- Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper
Where Crinecerfont is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | medium | 1 | 28 Apr 2026 | — | FDA |
Why Crinecerfont is in shortage
- product discontinuation — e.g. “Neurocrine is discontinuing only the 25 mg soft gel capsule dose strength (NDC 70370-5025-01). The 50mg and 100mg soft gel capsule dose strength (NDC 70370-5050-1 and 70370-5100-1)…” (United States)
Frequently asked questions
Is Crinecerfont currently in shortage?
Yes. As of the latest regulator updates, Crinecerfont has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Crinecerfont in shortage?
Regulators attribute the current Crinecerfont shortages to product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Crinecerfont shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Crinecerfont status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.